Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells

LI Ben-Shang; LUO Chang-Ying; HE Ying-Yi; JIANG Hua; GU Long-Jun

PDF(1335 KB)

Chinese Journal of Contemporary Pediatrics ›› 2010, Vol. 12 ›› Issue (07) : 557-562.

EXPERIMENTAL RESEARCH

Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells

LI Ben-Shang, LUO Chang-Ying, HE Ying-Yi, JIANG Hua, GU Long-Jun

Author information +

History +

Abstract

OBJECTIVE: To study the antileukemic activity of L-asparaginase through determining the changes of 4 kinds of amino acids (Asn, Aspa, Glu and Gln) in cell culture medium. METHODS: Following L-Asp treatment with designed concentrations and duration, the IC50 (inhibitory concentration 50%) of 8 kinds of common leukemia cell lines (U937, HL-60, Jurkat, NB4, THP-1, Namalwa, Karpass299, K562) were determined by CCK-8 assay. The changes of the 4 kinds of amino acids mentioned above were detected by high performance liquid chromatography (HPLC). RESULTS: The asparagines in cell culture medium were rapidly exhausted when treated with 0.01 U/mL L-Asp for 4 hrs or 1 U/mL L-Asp for 5 minutes. There were significant differences in the sensitivities to L-Asp of different leukemia cell lines. The sensitivities to L-Asp of various cell lines were dose-dependent. Low concentration of L-Asp resulted in a low IC50 and the IC50 increased following the L-Asp concentration increased. CONCLUSIONS: Different leukemia cell lines have different sensitivities to L-Asp, suggesting that exhaustion of asparagines around leukemia cells could not reflect the treatment efficacy of L-Asp. L-Asp antileukemic activity is dose-dependent, which suggests the importance of high-dose L-Asp on childhood acute lymphoblastic leukemia. ［Chin J Contemp Pediatr, 2010, 12 (7):557-562］

Key words

L-asparaginase / Leukemia / Asn / Cell line

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LI Ben-Shang, LUO Chang-Ying, HE Ying-Yi, JIANG Hua, GU Long-Jun. Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(07): 557-562

References

［1］Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation ［J］. N Engl J Med, 2009, 360(26):2730-2741.
［2］Pui CH, Evans WE, Relling MV. Are children with lesser-risk B-lineage acute lymphoblastic leukemia curable with antimetabolite therapy? ［J］. Nat Clin Pract Oncol, 2008, 5(3):130-131.
［3］Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia ［J］. Engl J Med, 2006, 354(2):166-178.
［4］Takagaki K, Katsuma S, Horio T, Kaminishi Y, Hada Y, Tanaka T, et al. cDNA microarray analysis of altered gene expression in Ara-C-treated leukemia cells ［J］. Biochem Biophys Res Commun, 2003, 309(2):351-358.
［5］Zhong C, Chen C, Kilberg MS. Characterization of the nutrient-sensing response unit in the human asparagine synthetase promoter ［J］. Biochem J, 2003, 372(Pt 2):603-609.
［6］Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, et al. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961) ［J］. Anticancer Res, 2004, 24(2C):1121-1125.
［7］Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01 ［J］. Blood, 2001, 97(5):1211-1218.
［8］Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial ［J］. Blood, 2002, 99(8):2734-2739.
［9］Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, et al. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia ［J］. J Clin Oncol, 2005, 23(28):7161-7167.
［10］Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase ［J］. J Clin Invest, 2007, 117(4):1049-1057.
［11］Irino T, Kitoh T, Koami K, Kashima T, Mukai K, Takeuchi E, et al. Establishment of realtime polymerase chain reaction method for quantitative analysis of asparagine synthetase expression ［J］. J Mol Diagn, 2004,6(3):217-224.
［12］Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER, et al. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia ［J］. Blood, 2005, 105(11):4223-4225.
［13］Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM. A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia ［J］. Cancer Res, 2005, 65(1):291-299.
［14］Aslanian AM, Fletcher BS, Kilberg MS. Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukaemia cells ［J］. Biochem J, 2001, 357(Pt 1):321-328.
［15］Li BS, Gu LJ, Luo CY, Li WS, Jiang LM, Shen SH, et al. The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L-asparaginase ［J］. Leukemia, 2006, 20(12):2199-2201.